Domperidone, Peripheral D2-like receptor antagonist

Be the first to review this product! Submit a review

|

(1 Publication)

MW 425.9 Da, Purity >99%. Peripheral D₂-like receptor antagonist. Does not readily cross the blood-brain barrier, and displays gastrokinetic and antiemetic properties.

View Alternative Names

3dopamine receptor, 5 HT 2B receptor, 5 HT(2B), 5 HT2 receptor, 5 HTT, 5 HTTLPR, 5 Hydroxytryptamine 2C receptor, 5 hydroxytryptamine (serotonin) receptor 2B, 5 hydroxytryptamine (serotonin) receptor 2B G protein coupled, 5 hydroxytryptamine (serotonin) transporter, 5 hydroxytryptamine 2B receptor, 5 hydroxytryptamine transporter, 5-HT-1C, 5-HT-2, 5-HTR2C, 5-ht-1c receptor, 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled, 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled, 5-hydroxytryptamine 2A receptor, 5-hydroxytryptamine receptor 1C, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C, 5HT transporter, 5HT2A_HUMAN, 5HT2B_HUMAN, 5HT2C_HUMAN, 5HT2F, ACLS, ADA1D_HUMAN, ADA2A_HUMAN, ADRA1A, ADRA1L1, ADRA2, ADRA2A, ADRA2R, ADRAR, AI838772, AP-1, ATAD5_HUMAN, ATPase family AAA domain containing 5, ATPase family AAA domain-containing protein 5, AW493413, Activator protein 1, Adra1d, Adrenergic alpha 1A receptor, Adrenergic alpha 1B receptor, Adrenergic alpha 1C receptor, Adrenergic alpha 1D receptor, Adrenergic alpha 2A receptor, Alpha 2AAR subtype C10, Alpha adrenergic receptor 1b, Alpha adrenergic receptor 1d, Alpha-1A adrenergic receptor, Alpha-1A adrenoreceptor, Alpha-1C adrenergic receptor, Alpha-1D adrenergic receptor, Alpha-1D adrenoceptor, Alpha-1D adrenoreceptor, Alpha-2 adrenergic receptor subtype C10, Alpha-2A adrenergic receptor, Alpha-2A adrenoceptor, Alpha-2A adrenoreceptor, Alpha-2AAR, Alpha-adrenergic receptor 1a, Alpha-adrenergic receptor 1c, Atherosclerosis, susceptibility to, included, BPHS, mouse, homolog of, BXR, C17orf41, Chromosome fragility-associated gene 1 protein, D(2) dopamine receptor, D(3) dopamine receptor, D2 dopamine receptor, D2DR, D2R, DKFZp686N23123, DNA binding protein, DRD2_HUMAN, DRD3_HUMAN, Dopamine D2 receptor, Dopamine D3 receptor, Dopamine receptor D2, Dopamine receptor D3, ELG1, ER, ER-alpha, ER-beta, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESRL 1, ESRR A, ESTR B, ETM1, Eag-related protein 1, Enhanced level of genomic instability 1 homolog, Enhancer Binding Protein AP1, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen resistance, included, Estrogen-related receptor alpha, Estrra, Ether a go go related potassium channel protein, Ether-a-go-go-related gene potassium channel 1, Ether-a-go-go-related protein 1, FET1, FLJ00280, FLJ00318, FLJ10847, FLJ11090, FLJ16020, FLJ16733, FRAG1, GCPS, GLI Kruppel family member GLI 3, GLI Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome), GLI family zinc finger 3, GLI3 C-terminally truncated form, GLI3 form of 190 kDa, GLI3 form of 83 kDa, GLI3 full length protein, GLI3-190, GLI3-83, GLI3FL, GLI3_HUMAN, Glioma associated oncogene family zinc finger 3, H(+)/organic cation antiporter kidney-specific, H+/organic cation antiporter, H-ERG, H1 R, HDL cholesterol, augmented response of, to hormone replacement, included, HH1R, HRH1_HUMAN, HTR 2, HTR 2A, HTR2, formerly, HTR2C, HisH1, Histamine H(1) receptor, Histamine H1 receptor, Histamine receptor H1, Histamine receptor subclass H1, Htr 2b, Htr1c, JUN protein, JUNC, JUN_HUMAN, Jun Activation Domain Binding Protein, Jun oncogene, Jun proto oncogene, K-OR-1, KCNH2_HUMAN, Kappa opioid receptor, Kappa-type opioid receptor, Kidney-specific H(+)/organic cation antiporter, Kv11.1, LMOR, LQT 2, M-OR-1, MATE-1, MATE-2, MATE2 B, MATE2 K, MGC102720, MGC104252, MGC112732, MGC6482, MOR, Mu opiate receptor, Mu opioid receptor, Mu-type opioid receptor, Multidrug and toxin extrusion 2, Multidrug and toxin extrusion protein 1, Multidrug and toxin extrusion protein 2, Myocardial infarction, susceptibility to, included, NP75 protein, NR1I2_HUMAN, NR2B1, NR3A1, NR3A2, NR3B1, Na+/Cl- dependent serotonin transporter, Neurotransmitter transporter, Norepinephrine transporter, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 2 group B member 1, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, OCD1, ONR 1, OPRK 1, OPRK_HUMAN, OPRM1, OPRM_HUMAN, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000022510, OTTHUMP00000058849, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Oncogene GLI3, Oncogene JUN, Opiate receptor kappa 1, Opioid receptor mu 1, Opioid receptor, kappa 1, Oprk2, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, PAP A, PAPB, PAR, PAR q, PPD IV, PRR, Potassium channel HERG, Potassium voltage gated channel subfamily H (eag related) member 2, Potassium voltage-gated channel subfamily H member 2, Pregnane X receptor, Proto-oncogene c-jun, R21, RNESTROR, RP24-311F12.2, RXR alpha1, RXRA_HUMAN, Retinoic acid receptor RXR-alpha, Retinoid X nuclear receptor alpha, Retinoid X receptor alpha, S47A1_HUMAN, S47A2_HUMAN, SC6A2_HUMAN, SC6A4_HUMAN, SCAN1, SEROTONIN 5HT2B RECEPTOR, SERT, SERT1, SLC47A1, SLC47A2, SLC6A5, SQT1, SXR, Serotonin 5-HT-2C receptor, Serotonin receptor 2A, Serotonin receptor 2B, Serotonin receptor 2C, Serotonin transporter 1, Slc6a2, Slc6a4, Sodium-dependent noradrenaline transporter, Sodium-dependent serotonin transporter, Solute carrier family 47 member 1, Solute carrier family 47 member 2, Solute carrier family 6 (neurotransmitter transporter norepinephrine) member 5, Solute carrier family 6 (neurotransmitter transporter) member 4, Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, Solute carrier family 6 member 2, Solute carrier family 6 member 4, Solute carrier family 6 member 5, Steroid and xenobiotic receptor, Steroid hormone receptor ERR1, Stomach fundus serotonin receptor, TYDP, TYDP1_HUMAN, Transcription factor AP-1, Transcriptional activator GLI3, Transcriptional repressor GLI3R, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, V jun sarcoma virus 17 oncogene homolog, V jun sarcoma virus 17 oncogene homolog (avian), V-jun avian sarcoma virus 17 oncogene homolog, Voltage gated potassium channel, subfamily H, member 2, Voltage-gated potassium channel subunit Kv11.1, Zinc finger protein GLI 3, alpha-2-adrenergic receptor, platelet type, cJun, chromosome fragility associated gene 1, eag homolog, estrogen receptor related receptor alpha, hERG-1, hERR1, hMATE-1, hMATE-2, hMOP, hSERT, multidrug and toxin extrusion 1, p39, pregnane X nuclear receptor variant 2, serotonin 1c receptor, serotonin 2c receptor, serotonin 5-HT-2 receptor, formerly, serotonin 5-HT-2A receptor, solute carrier family 6 (neurotransmitter transporter, serotonin), member 4